Start with the dose change and the symptom pattern
The current semaglutide labels make clear that gastrointestinal reactions are a core part of the safety profile and that dose escalation exists partly to reduce the risk of those reactions. That means a strong timeline starts with when the product was started, whether the dose recently changed, and exactly when nausea, vomiting, bloating, constipation, or pain became severe.
Be specific about severity. It helps to note whether food stayed down, whether fluids stayed down, how long vomiting lasted, whether weight loss or dehydration was discussed, and whether symptoms improved after holding or stopping the medication.
Capture the medical response, not just the symptoms
NIDDK explains that evaluation for delayed gastric emptying and pancreatitis is based on the symptom pattern together with exam findings, testing, and imaging. That is why the documentation should include where care was sought, whether IV fluids were needed, what tests were ordered, and what the discharge or follow-up plan said.
If a clinician mentioned gastroparesis, ileus, bowel obstruction, pancreatitis, dehydration, or another GI diagnosis, write down the exact wording. Even a short after-visit summary or portal note can matter later.
Build one clean record packet
The easiest way to avoid confusion later is to gather the medication history, symptom notes, ER or urgent care records, lab results, imaging, discharge instructions, and follow-up visits into one dated packet. HHS guidance is useful here because it reminds patients that medical and billing records can be requested rather than hunted down informally.
The goal is to make later medical or legal conversations more accurate and less dependent on memory.